CAI
Income statement / Annual
Last year (2024), Caris Life Sciences, Inc.'s total revenue was $412.26 M,
an increase of 34.67% from the previous year.
In 2024, Caris Life Sciences, Inc.'s net income was -$281.89 M.
See Caris Life Sciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$412.26 M |
$306.13 M |
$258.49 M |
$294.01 M |
$416.54 M |
$432.10 M |
$348.39 M |
$294.35 M |
$249.67 M |
$227.59 M |
| Cost of Revenue |
$233.48 M
|
$216.82 M
|
$178.46 M
|
$109.86 M
|
$216.03 M
|
$218.47 M
|
$179.11 M
|
$156.86 M
|
$123.76 M
|
$77.98 M
|
| Gross Profit |
$178.78 M
|
$89.31 M
|
$80.02 M
|
$184.16 M
|
$200.51 M
|
$213.63 M
|
$169.29 M
|
$137.50 M
|
$125.91 M
|
$149.61 M
|
| Gross Profit Ratio |
0.43
|
0.29
|
0.31
|
0.63
|
0.48
|
0.49
|
0.49
|
0.47
|
0.5
|
0.66
|
| Research and Development Expenses |
$113.92 M
|
$116.88 M
|
$101.27 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$173.56 M
|
$151.95 M
|
$156.15 M
|
$27.31 M
|
$52.70 M
|
$50.31 M
|
$42.70 M
|
$35.68 M
|
$27.62 M
|
$0.00
|
| Selling & Marketing Expenses |
$148.30 M
|
$139.53 M
|
$138.36 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$321.86 M
|
$291.48 M
|
$294.51 M
|
$27.31 M
|
$52.70 M
|
$50.31 M
|
$42.70 M
|
$35.68 M
|
$27.62 M
|
$0.00
|
| Other Expenses |
$128.00 K
|
$500.00 K
|
$0.00
|
$17.76 M
|
$17.53 M
|
$14.55 M
|
$20.92 M
|
$35.86 M
|
$30.19 M
|
$52.58 M
|
| Operating Expenses |
$435.90 M
|
$408.86 M
|
$395.78 M
|
$45.07 M
|
$70.23 M
|
$64.85 M
|
$63.62 M
|
$71.54 M
|
$57.81 M
|
$52.58 M
|
| Cost And Expenses |
$669.38 M
|
$625.68 M
|
$574.24 M
|
$154.93 M
|
$286.26 M
|
$283.32 M
|
$242.72 M
|
$228.40 M
|
$181.57 M
|
$130.56 M
|
| Interest Income |
$7.12 M
|
$11.26 M
|
$947.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$7.00 K
|
| Interest Expense |
$50.03 M
|
$31.61 M
|
$26.68 M
|
$61.57 M
|
$79.16 M
|
$78.35 M
|
$53.05 M
|
$42.75 M
|
$36.03 M
|
$35.21 M
|
| Depreciation & Amortization |
$48.91 M
|
$49.00 M
|
$48.25 M
|
$110.65 M
|
$113.93 M
|
$123.48 M
|
$113.26 M
|
$106.68 M
|
$114.24 M
|
$78.83 M
|
| EBITDA |
-$182.95 M |
-$260.80 M |
-$245.89 M |
$254.46 M |
$248.30 M |
$283.31 M |
$223.51 M |
$159.27 M |
$181.36 M |
$181.51 M |
| EBITDA Ratio |
-0.44
|
-0.85
|
-0.95
|
0.87
|
0.6
|
0.66
|
0.64
|
0.54
|
0.73
|
0.8
|
| Operating Income Ratio |
-0.62
|
-1.04
|
-1.22
|
0.47
|
0.31
|
0.34
|
0.3
|
0.22
|
0.27
|
0.43
|
| Total Other Income/Expenses Net |
-$24.77 M
|
-$21.86 M
|
-$5.07 M
|
-$109.55 M
|
$0.00
|
-$67.30 M
|
-$48.47 M
|
-$56.08 M
|
-$36.87 M
|
-$29.46 M
|
| Income Before Tax |
-$281.89 M
|
-$341.42 M
|
-$320.83 M
|
$29.53 M
|
$55.21 M
|
$81.48 M
|
$57.20 M
|
$9.88 M
|
$31.22 M
|
$67.58 M
|
| Income Before Tax Ratio |
-0.68
|
-1.12
|
-1.24
|
0.1
|
0.13
|
0.19
|
0.16
|
0.03
|
0.13
|
0.3
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$1.80 M
|
$4.19 M
|
$2.89 M
|
-$14.86 M
|
$3.84 M
|
$4.25 M
|
$7.19 M
|
| Net Income |
-$281.89 M
|
-$341.42 M
|
-$320.83 M
|
$27.73 M
|
$31.01 M
|
$78.60 M
|
$72.06 M
|
$6.00 M
|
$26.84 M
|
$60.27 M
|
| Net Income Ratio |
-0.68
|
-1.12
|
-1.24
|
0.09
|
0.07
|
0.18
|
0.21
|
0.02
|
0.11
|
0.26
|
| EPS |
-2.7 |
-1.82 |
-1.57 |
1.55 |
1.72 |
3.97 |
3.74 |
0.31 |
1.29 |
2.91 |
| EPS Diluted |
-2.7 |
-1.82 |
-1.57 |
1.55 |
1.72 |
3.97 |
3.68 |
0.31 |
1.28 |
2.85 |
| Weighted Average Shares Out |
$254.66 M
|
$254.66 M
|
$254.79 M
|
$17.95 M
|
$18.01 M
|
$19.82 M
|
$19.25 M
|
$19.32 M
|
$20.77 M
|
$20.73 M
|
| Weighted Average Shares Out Diluted |
$254.66 M
|
$254.66 M
|
$254.79 M
|
$17.95 M
|
$18.01 M
|
$19.82 M
|
$19.61 M
|
$19.39 M
|
$20.99 M
|
$21.16 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
